Clinical Ovarian Cancer - Volume 1 - Issue 2

Highlights from: The 44th Annual Meeting of the American Society of Clinical Oncology May 30-June 3, 2008; Chicago, IL

Fulltext Access 5 Pages 2008

CON: Therapy for a Patient with Platinum-Resistant/Refractory Ovarian Cancer Should Not Be Selected Based on Results of an In Vitro Extreme Drug Sensitivity/Resistance Assay

Fulltext Access 5 Pages 2008

CON: Not All Patients with Endometrial Cancer with Extrauterine Disease Should Receive Chemotherapy After Any Indicated Surgery

Fulltext Access 4 Pages 2008

Issues in the Design of Ovarian Cancer Trials Evaluating Antineoplastic Agents Not Predicted to Cause Regression of Existing Tumor Masses

Fulltext Access 5 Pages 2008

Bevacizumab in the Management of Epithelial Ovarian Cancer

Fulltext Access 4 Pages 2008

Platelet-Derived Growth Factor Pathway Inhibitors in Ovarian Cancer

Fulltext Access 7 Pages 2008

Preoperative Serum Levels of Epidermal Growth Factor Receptor, HER2, and Vascular Endothelial Growth Factor in Malignant and Benign Ovarian Tumors

Fulltext Access 8 Pages 2008

The Use of Radiofrequency Ablation in Advanced Ovarian Cancer: Resection and Ablation of Liver Metastases

Fulltext Access 4 Pages 2008